|
Vaccine Detail
rVEE-HA(H1N1) |
Vaccine Information |
- Vaccine Name: rVEE-HA(H1N1)
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004784
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- HA
gene engineering:
- Type: Recombinant vector construction
- Description: The HA gene was transferred into the VEE vector (Davis et al., 1996).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: (Davis et al., 1996) a VEE vector containing the complete influenza virus hemagglutinin (HA) gene of H1N1 influenza virus.
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccination Protocol: Mice were immunized by subcutaneous inoculation of 10^4 PFU of vector without insert or HA vector in a 10-µl volume of diluent into each rear footpad (Davis et al., 1996).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Immunized mice were challenged intranasally with a virulent strain of influenza virus (Davis et al., 1996).
- Efficacy: For the immunized mice, replication of challenge virus in their lungs was restricted, and they were completely protected from signs of disease (Davis et al., 1996).
|
References |
Davis et al., 1996: Davis NL, Brown KW, Johnston RE. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. Journal of virology. 1996; 70(6); 3781-3787. [PubMed: 8648713].
|
|